Which company develops and produces Lorlatinib?

Lolatinib (Lorlatinib) is an innovative drug developed and produced by Pfizer Inc. (Pfizer Inc.). Pfizer is a leading global pharmaceutical company headquartered in New York City, United States. The company has a long history in the medical field and has been committed to developing and manufacturing a variety of drugs to meet the medical needs of patients, especially in the field of cancer.

Lorlatinib is a targeted therapy drug specifically used to treat ALK (tyrosine kinase) and ROS1 positive non-small cell lung cancer (NSCLC). It effectively controls the growth and spread of tumors by inhibiting abnormal signaling pathways triggered by these specific gene mutations. The development of lorlatinib represents Pfizer's innovation and efforts in the field of cancer treatment and provides new treatment hope for lung cancer patients.

This drug has undergone rigorous clinical trials and research and has been approved by many countries and regions for the treatment of patients in compliance with the indications. It has achieved remarkable results in improving patient survival, alleviating symptoms and improving quality of life.

In short, lorlatinib is an innovative targeted therapy drug developed and produced by Pfizer Pharmaceuticals, which provides an important treatment option for patients with ALK and ROS1 positive non-small cell lung cancer. Pfizer is committed to continuously advancing the advancement of medical science to provide patients with better health and quality of life.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original drugs and cheaper generic drugs abroad. The cheaper ones are the original drugs from Turkey, which cost more than 1,000 yuan, and the original drugs from Hong Kong, China, which cost about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.